Package 75834-133-05

Brand: rivastigmine tartrate

Generic: rivastigmine tartrate
NDC Package

Package Facts

Identity

Package NDC 75834-133-05
Digits Only 7583413305
Product NDC 75834-133
Product ID 75834-133_e272f7d1-d782-4ff1-919c-784c91ee024d
Description

500 CAPSULE in 1 BOTTLE, PLASTIC (75834-133-05)

Marketing

Marketing Status
Marketed Since 2017-09-04
Brand rivastigmine tartrate
Generic rivastigmine tartrate
Sample Package No

Linked Drug Pages (1)

RIVASTIGMINE TARTRATE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "e272f7d1-d782-4ff1-919c-784c91ee024d", "openfda": {"upc": ["0375834133607", "0375834134604", "0375834135601", "0375834136608"], "unii": ["9IY2357JPE"], "rxcui": ["312835", "312836", "314214", "314215"], "spl_set_id": ["83bd2ff6-1d8b-4cac-a37b-fd01dc3f34a1"], "manufacturer_name": ["Nivagen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 CAPSULE in 1 BOTTLE, PLASTIC (75834-133-05)", "package_ndc": "75834-133-05", "marketing_start_date": "20170904"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE, PLASTIC (75834-133-60)", "package_ndc": "75834-133-60", "marketing_start_date": "20170904"}], "brand_name": "RIVASTIGMINE TARTRATE", "product_id": "75834-133_e272f7d1-d782-4ff1-919c-784c91ee024d", "dosage_form": "CAPSULE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "75834-133", "generic_name": "RIVASTIGMINE TARTRATE", "labeler_name": "Nivagen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RIVASTIGMINE TARTRATE", "active_ingredients": [{"name": "RIVASTIGMINE TARTRATE", "strength": "1.5 mg/1"}], "application_number": "ANDA203844", "marketing_category": "ANDA", "marketing_start_date": "20170904", "listing_expiration_date": "20261231"}